drugset / Trial / NCT01612273
The Effect of Triflusal on Peripheral Microcirculation Dysfunction
RandomizedCrossoverQuadruple-blindTreatment
Summary
To explore the efficacy of triflusal in patients with symptomatic peripheral microcirculation dysfunction. Triflusal is a salicylate compound approved in several countries as antithrombotic agent and it additionally has vasodilatory effect. The hypothesis is to explore if there is a improvement of peripheral microcirculation by triflusal.
Timeline
- Start
- 2011-04
- Primary completion
- 2013-01
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 150 mg | Oral |
| Subject | Triflusal | Small molecule | 300 mg | Oral |